What is the prevalence of BRAF mutations in patients with conjunctival melanoma?

Updated: Feb 16, 2021
  • Author: Manolette R Roque, MD, MBA, FPAO; Chief Editor: Hampton Roy, Sr, MD  more...
  • Print


BRAF / Overview/Clinical Implications and Genetic Testing">BRAF mutations appeared in 35% of reported cases of conjunctival melanoma in Denmark. [7] Ongoing clinical trials are evaluating the role of targeted therapies as both adjuvant and metastatic treatment in conjunctival melanoma. This is potentially useful for advanced nonresectable cases. [29]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!